查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1935606

全球干细胞库市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Stem Cell Banking Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 143 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计干细胞库市场规模将从 2025 年的 115.9 亿美元成长到 2034 年的 248.3 亿美元，2026 年至 2034 年的复合年增长率为 8.84%。

由于人们对干细胞治疗潜力的认识不断提高，以及再生医学需求的日益增长，干细胞库市场预计将迎来显着增长。随着研究不断揭示干细胞在治疗包括癌症、神经系统疾病和心血管疾病在内的多种疾病的潜力，对可靠的干细胞保存方案的需求也随之飙升。干细胞库为干细胞的采集、处理和储存提供安全的环境，确保其在未来治疗应用中的活性。冷冻保存和生物银行技术的创新正在提高干细胞保存的效率和安全性，使这些服务对医疗机构和患者更具吸引力。

此外，个人化医疗的日益普及也对干细胞库市场产生了影响。随着医疗服务提供者越来越认识到根据患者个别需求量身定制治疗方案的重要性，自体干细胞库的需求也日益增长，患者可以自行储存干细胞以备将来使用。这一趋势在再生医学领域尤其重要，因为使用患者自身的细胞可以降低排斥反应的风险并改善治疗效果。此外，公共干细胞库的兴起（这些干细胞库广泛提供捐赠干细胞的储存服务）正在扩大市场，并促进干细胞在研究和临床应用中的使用。

此外，干细胞治疗领域研发投入的不断增加，正推动干细胞库市场的创新。学术机构、研究组织和生物製药公司之间的合作，促进了干细胞技术的进步，确保新的采集和保存方法能够满足市场不断变化的需求。消费者对干细胞库益处的认识不断提高，也促进了市场成长，越来越多的人希望透过干细胞保存来保障自身健康。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 绘製渗透率和成长前景图
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会
    • 市场问题
  • 波特五力分析
  • PESTLE分析

4. 全球干细胞库市场（依来源划分）

  • 市场分析、洞察与预测
  • 胎盘干细胞（PSCS）
  • 脂肪组织来源干细胞（ADSCS）
  • 骨髓干细胞（BMSCs）
  • 人类胚胎干细胞（HESCs）
  • 牙髓干细胞（DPSCS）
  • 其他的

5. 全球干细胞库市场按服务类型划分

  • 市场分析、洞察与预测
  • 样品保存储存
  • 样品分析
  • 样品处理
  • 检体采集与运输

6. 全球干细胞库市场（依应用划分）

  • 市场分析、洞察与预测
  • 个性化银行应用程式
  • 研究用途
  • 临床应用

7. 全球干细胞库市场（按地区划分）

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商格局（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Cord Blood Registry（CBR）Systems
    • Cordlife Group Limited
    • Cryo-Cell International
    • ViaCord
    • Cryo-Save AG
    • LifeCell International
    • StemCyte
    • Global Cord Blood Corporation
    • Smart Cells International
    • Vita34 AG
    • CryoHoldco
简介目录
Product Code: VMR11211839

The Stem Cell Banking Market size is expected to reach USD 24.83 Billion in 2034 from USD 11.59 Billion (2025) growing at a CAGR of 8.84% during 2026-2034.

The stem cell banking market is poised for significant growth, driven by the increasing awareness of the therapeutic potential of stem cells and the rising demand for regenerative medicine. As research continues to unveil the capabilities of stem cells in treating various diseases, including cancer, neurological disorders, and cardiovascular diseases, the need for reliable stem cell storage solutions is surging. Stem cell banks provide a secure environment for the collection, processing, and storage of stem cells, ensuring their viability for future therapeutic applications. Innovations in cryopreservation techniques and biobanking technologies are enhancing the efficiency and safety of stem cell storage, making these services more appealing to both healthcare providers and patients.

Moreover, the growing emphasis on personalized medicine is influencing the stem cell banking market. As healthcare providers increasingly recognize the importance of tailoring treatments to individual patient needs, the demand for autologous stem cell banking-where patients store their own stem cells for future use-is rising. This trend is particularly relevant in the context of regenerative therapies, where the use of a patient's own cells can reduce the risk of rejection and improve treatment outcomes. Additionally, the rise of public stem cell banks, which offer accessible storage options for donated stem cells, is expanding the market and promoting the use of stem cells in research and clinical applications.

Furthermore, the increasing focus on research and development in the field of stem cell therapy is fostering innovation in the stem cell banking market. Collaborations between academic institutions, research organizations, and biopharmaceutical companies are driving advancements in stem cell technologies, ensuring that new methods for collection and storage meet the evolving needs of the market. The growing awareness of the benefits of stem cell banking among consumers is also contributing to market growth, as more individuals seek to secure their health and wellness through stem cell preservation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Source

  • Placental Stem Cells (PSCS)
  • Adipose Tissue-Derived Stem Cells (ADSCS)
  • Bone Marrow-Derived Stem Cells (BMSCS)
  • Human Embryo-Derived Stem Cells (HESCS)
  • Dental Pulp-Derived Stem Cells (DPSCS)
  • Others

By Service Type

  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection and Transportation

By Application

  • Personalized Banking Applications
  • Research Applications
  • Clinical Application

COMPANIES PROFILED

  • Cord Blood Registry CBR Systems, Cordlife Group Limited, CryoCell International, ViaCord, CryoSave AG, LifeCell International, StemCyte, Global Cord Blood Corporation, Smart Cells International, Vita34 AG, CryoHoldco

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL STEM CELL BANKING MARKET: BY SOURCE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Source
  • 4.2. Placental Stem Cells (PSCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Adipose Tissue-Derived Stem Cells (ADSCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Bone Marrow-Derived Stem Cells (BMSCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Human Embryo-Derived Stem Cells (HESCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Dental Pulp-Derived Stem Cells (DPSCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STEM CELL BANKING MARKET: BY SERVICE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Service Type
  • 5.2. Sample Preservation and Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Sample Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Sample Processing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Sample Collection and Transportation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STEM CELL BANKING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Personalized Banking Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Research Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Clinical Application Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL STEM CELL BANKING MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Source
    • 7.2.2 By Service Type
    • 7.2.3 By Application
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Source
    • 7.3.2 By Service Type
    • 7.3.3 By Application
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Source
    • 7.4.2 By Service Type
    • 7.4.3 By Application
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Source
    • 7.5.2 By Service Type
    • 7.5.3 By Application
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Source
    • 7.6.2 By Service Type
    • 7.6.3 By Application
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL STEM CELL BANKING INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Cord Blood Registry (CBR) Systems
    • 9.2.2 Cordlife Group Limited
    • 9.2.3 Cryo-Cell International
    • 9.2.4 ViaCord
    • 9.2.5 Cryo-Save AG
    • 9.2.6 LifeCell International
    • 9.2.7 StemCyte
    • 9.2.8 Global Cord Blood Corporation
    • 9.2.9 Smart Cells International
    • 9.2.10 Vita34 AG
    • 9.2.11 CryoHoldco